[elfsight_social_share_buttons id=”1″] Adding Cash Positions to the Portfolio Tracker
- Categories:
- Financial Issues
[elfsight_social_share_buttons id=”1″] Adding Cash Positions to the Portfolio Tracker
New Zealand farmers on Thursday gathered in city and town centers across the country, driving tractors and pickup trucks and carrying signs in protest against the government’s plan to tax … cow and sheep burps.
The incident unfolded when Rorie Woods, a 55-year-old professional beekeeper, drove up to the home in Longmeadow while deputies were in the process of enforcing the eviction notice, the sheriff’s department said in a statement on Wednesday.
Yesterday, Truss announced that she was resigning as British prime minister just six weeks after she was appointed, brought down by an economic program that sent shockwaves through financial markets last month and divided her Conservative Party.
Students hoping to have up to $20,000 in federal student loan debt forgiven might have to wait longer than expected to see their debt total drop following a new filing with the Supreme Court on Wednesday.
Human rights groups said that unarmed civilians were massacred as security forces brutally cracked down on demonstrations in the capital, N’Djamena, and several other cities.
Austin Nola won the battle of brothers to change his team’s playoff fortune. Nola hit an RBI single off younger brother, Aaron, to spark a five-run inning and lead the San Diego Padres to overcome a 4-0 deficit to defeat the Philadelphia Phillies 8-5 on Wednesday evening in the National League Championship Series. The series is now tied at 1-1.
Election prognosticators continue to forecast many happy returns for the GOP this November. With less than a month until Election Day and early voting underway in many states, Republicans are making inroads even in dark blue states.
Ukraine is facing its first large-scale power disruptions since Russia’s Feb. 24 invasion following another night of Russian air and drone strikes on critical infrastructure facilities.
Advisers to the U.S. Food and Drug Administration on Wednesday voted in favor of removing Covis Pharma’s drug for preventing preterm birth from the market several years after its approval, following a failed study.